Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ubiquitin specific peptidase 3 (USP3) is a deubiquitinating enzyme belonging to the ubiquitin-specific protease family. It functions by removing ubiquitin molecules from specific protein substrates, thereby preventing their proteasomal degradation and maintaining protein homeostasis[5]. USP3 is involved in several key biological processes, including regulation of the cell cycle, DNA damage repair (notably by deubiquitinating histone H2A and γH2AX at DNA damage sites), and innate immune signaling through stabilization of adapter proteins like ASC during inflammasome assembly[1][4][5]. Overexpression or dysregulation of USP3 has been implicated in the progression of various cancers, where it can promote proliferation, migration, and invasion of tumor cells—partly via stabilization of effectors such as EPHA2 and activation of the PI3K/AKT pathway[2]. USP3 is also involved in antiviral defense, such as inhibiting HIV-1 by stabilizing A3G, an intrinsic antiviral factor[3]. As a result, USP3 is being explored as a potential therapeutic target in oncology, immunology, and infectious diseases, though specific pharmacological inhibitors are not yet clinically available[5].
Inhibition of USP3 leads to increased ubiquitination and degradation of specific substrate proteins, affecting cell cycle progression, DNA repair, and immune signaling[2][5] Modulation of USP3 can alter inflammatory responses and cellular tolerance via targets such as ASC[1][5]
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ubiquitin specific peptidase 3 (USP3).